2020 2021 Q3 and Q4 PII KMPT Report
- Publication date:
- 19 July 2021
- Date range:
- 2020 - 2021
Treatment of Adults with Severe Postpartum Depression
Quarter reported
Quarter 3
Research and Ethics Committee Reference
20/LO/1044
IRAS number
287176
Name of Trial
A Randomized, Double-Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of SAGE-217 in the Treatment of Adults with Severe Postpartum Depression.
First patient recruited
No
Date of first patient recruited
Date site invited
18 June 2020
Date site selected
2 September 2020
HRA approval date
25 November 2020
Date site confirmed by sponsor
31 March 2021
Date site confirmed
31 March 2021
Date site ready to start
26 April 2021
Benchmark met
No
Reason for delay
No patients consented
Comments
Contracting delays during set-up due use of non-model commercial agreement. Challenging eligibility criteria required for study.
Reasons for delay correspond to:
Both